Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: Results of a multicentre, randomised controlled trial

Gillian Dean; Suneeta Soni; Rachel Pitt; Jonathan Ross; Caroline Sabin; Jennifer Whetham

doi:10.1136/sextrans-2020-054468

Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: Results of a multicentre, randomised controlled trial

Gillian Dean^*, Suneeta Soni, Rachel Pitt, Jonathan Ross, Caroline Sabin, Jennifer Whetham

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6 Citations (SciVal)

Original language	English
Pages (from-to)	177-182
Number of pages	6
Journal	Sexually Transmitted Infections
Volume	97
Issue number	3
DOIs	https://doi.org/10.1136/sextrans-2020-054468
Publication status	Published (VoR) - 1 May 2021

Funding

Disclaimer This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0609–19279). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

Keywords

azithromycin
mycoplasma
pelvic inflammatory disease

Access to Document

10.1136/sextrans-2020-054468

Cite this

@article{692d72321ec944f4837995105f92ec65,

title = "Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: Results of a multicentre, randomised controlled trial",

keywords = "azithromycin, mycoplasma, pelvic inflammatory disease",

author = "Gillian Dean and Suneeta Soni and Rachel Pitt and Jonathan Ross and Caroline Sabin and Jennifer Whetham",

note = "Funding Information: Disclaimer This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0609–19279). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Publisher Copyright: {\textcopyright} ",

year = "2021",

month = may,

day = "1",

doi = "10.1136/sextrans-2020-054468",

language = "English",

volume = "97",

pages = "177--182",

journal = "Sexually Transmitted Infections",

issn = "1368-4973",

publisher = "BMJ Publishing Group",

number = "3",

}

Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: Results of a multicentre, randomised controlled trial. / Dean, Gillian; Soni, Suneeta; Pitt, Rachel et al.
In: Sexually Transmitted Infections, Vol. 97, No. 3, 01.05.2021, p. 177-182.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole

T2 - Results of a multicentre, randomised controlled trial

AU - Dean, Gillian

AU - Soni, Suneeta

AU - Pitt, Rachel

AU - Ross, Jonathan

AU - Sabin, Caroline

AU - Whetham, Jennifer

N1 - Funding Information: Disclaimer This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0609–19279). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Publisher Copyright: ©

PY - 2021/5/1

Y1 - 2021/5/1

KW - azithromycin

KW - mycoplasma

KW - pelvic inflammatory disease

UR - https://www.scopus.com/pages/publications/85096184538

UR - https://www.scopus.com/inward/citedby.url?scp=85096184538&partnerID=8YFLogxK

U2 - 10.1136/sextrans-2020-054468

DO - 10.1136/sextrans-2020-054468

M3 - Article

C2 - 33188138

AN - SCOPUS:85096184538

SN - 1368-4973

VL - 97

SP - 177

EP - 182

JO - Sexually Transmitted Infections

JF - Sexually Transmitted Infections

IS - 3

ER -

Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: Results of a multicentre, randomised controlled trial

Funding

Keywords

Access to Document

Other files and links

Fingerprint

Cite this